# Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: The First Affiliated Hospital with Nanjing Medical University · Condition: Metastatic Colorectal Cancer

- Company: The First Affiliated Hospital with Nanjing Medical University
- Sector: Metastatic Colorectal Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07718490

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.